Safety and Efficacy of Urtica Dioica Cataplasm in the Management of Osgood-Schlatter Disease in Young Athletes
In plain words A study of stinging Nettle in male participants 7 to 15, run by Faculty of Medicine, Sousse. It plans to enroll about 90 people and lists no sites yet.
Who it lists and where
Who the trial lists, as registered
Lists male participants 7 to 15. Conditions: Osgood-Schlatter Disease.
- Healthy male children between 7 and 15 years of age
- Active in regular sports practice (e.g., football)
- Clinically confirmed diagnosis of OSD
The exclusion criteria are on the listing.
What it tests, as registered
Urtica dioica cataplasm; Placebo; Vitamin D; Resting conditions
Registered summary
The primary objective of this clinical trial is to evaluate the efficacy and safety of a topical Urtica dioica cataplasm in managing knee pain and functional limitations in athletic children diagnosed with Osgood-Schlatter Disease. Efficacy will be assessed through changes in knee pain using the Visual Analog Scale (VAS) and functional outcomes using the Knee Injury and Osteoarthritis Outcome Score (KOOS). The full summary is on the listing.
Where, as registered
No sites listed yet.